AAAAAA

   
Results: 1-8 |
Results: 8
Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation
Authors: Frantsve, J Schwaller, J Sternberg, DW Kutok, J Gilliland, DG
Citation: J. Frantsve et al., Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation, MOL CELL B, 21(10), 2001, pp. 3547-3557
The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologicdisease in vivo
Authors: Andreasson, P Schwaller, J Anastasiadou, E Aster, J Gilliland, DG
Citation: P. Andreasson et al., The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologicdisease in vivo, CANC GENET, 130(2), 2001, pp. 93-104
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)
Authors: Schwaller, J Anastasiadou, E Cain, D Kutok, J Wojiski, S Williams, IR LaStarza, R Crescenzi, B Sternberg, DW Andreasson, P Schiavo, R Siena, S Mecucci, C Gilliland, DG
Citation: J. Schwaller et al., H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22), BLOOD, 97(12), 2001, pp. 3910-3918
Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
Authors: Schwaller, J Parganas, E Wang, DM Cain, D Aster, JC Williams, IR Lee, CK Gerthner, R Kitamura, T Frantsve, J Anastasiadou, E Loh, ML Levy, DE Ihle, JN Gilliland, DG
Citation: J. Schwaller et al., Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2, MOL CELL, 6(3), 2000, pp. 693-704
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14(ARF) /p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia
Authors: Pabst, T Peters, UR Tinguely, M Schwaller, J Tschan, M Aebi, S Vonlanthen, S Borisch, B Betticher, DC Zimmermann, A Tobler, A Fey, MF
Citation: T. Pabst et al., Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14(ARF) /p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia, LEUK LYMPH, 37(5-6), 2000, pp. 639-648
Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia
Authors: Liu, Q Schwaller, J Kutok, J Cain, D Aster, JC Williams, IR Gilliland, DG
Citation: Q. Liu et al., Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia, EMBO J, 19(8), 2000, pp. 1827-1838
Interleukin-8 expression by fetal and neonatal pulmonary cells in hyaline membrane disease and amniotic infection
Authors: Gahler, A Stallmach, T Schwaller, J Fey, MF Tobler, A
Citation: A. Gahler et al., Interleukin-8 expression by fetal and neonatal pulmonary cells in hyaline membrane disease and amniotic infection, PEDIAT RES, 48(3), 2000, pp. 299-303
TEL/PDGF beta R induces hematologic malignancies in mice that respond to aspecific tyrosine kinase inhibitor
Authors: Tomasson, MH Williams, IR Hasserjian, R Udomsakdi, C McGrath, SM Schwaller, J Druker, B Gilliland, DG
Citation: Mh. Tomasson et al., TEL/PDGF beta R induces hematologic malignancies in mice that respond to aspecific tyrosine kinase inhibitor, BLOOD, 93(5), 1999, pp. 1707-1714
Risultati: 1-8 |